Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Iradimed (IRMD) Other financing activities (2016)

Iradimed (IRMD) has disclosed Other financing activities for 3 consecutive years, with $53122.0 as the latest value for Q4 2016.

  • Quarterly Other financing activities fell 93.75% to $53122.0 in Q4 2016 from the year-ago period, while the trailing twelve-month figure was $603553.0 through Dec 2016, down 65.08% year-over-year, with the annual reading at -$1.1 million for FY2025, 763.36% down from the prior year.
  • Other financing activities for Q4 2016 was $53122.0 at Iradimed, down from $284337.0 in the prior quarter.
  • The five-year high for Other financing activities was $1.8 million in Q3 2014, with the low at -$1.9 million in Q4 2014.
  • Average Other financing activities over 3 years is $229415.1, with a median of $160974.0 recorded in 2015.
  • Peak annual rise in Other financing activities hit 320.65% in 2016, while the deepest fall reached 93.75% in 2016.
  • Over 3 years, Other financing activities stood at -$1.9 million in 2014, then surged by 145.26% to $850449.0 in 2015, then crashed by 93.75% to $53122.0 in 2016.
  • According to Business Quant data, Other financing activities over the past three periods came in at $53122.0, $284337.0, and $209515.0 for Q4 2016, Q3 2016, and Q2 2016 respectively.